[en] Thrombin is thought to mediate, through protease-activated receptors, both protective as well as cytotoxic effects. As thrombin receptors are expressed in the CNS, an important question arises as to whether the intact nervous system is able to generate thrombin by activation of its precursor prothrombin, derived endogenously or only upon extravasation following brain injury. To address this question, transgenic mice that express C-terminally haemagglutinin tagged human prothrombin in post-mitotic neurones were generated. In situ hybridization and immunohistochemical analysis showed abundant and widespread cerebral expression of the transgene. Amidolytic assays of brain homogenates and hippocampal slice cultures demonstrated that activation of transgenic prothrombin required added factors, such as snake venom or blood components. This strongly suggests that any possible action of thrombin in the adult CNS depends on blood-derived factors that activate prothrombin. Furthermore, the results are consistent with the idea that in the non-pathological situation an as yet unidentified ligand activates thrombin receptors in the nervous system.
Disciplines :
Neurology
Author, co-author :
Sinnreich, Michael; Friedrich-Miescher Institute for Biomedical Research, Basel, Switzerland.
Meins, Marita
NICLOU, Simone P. ; Friedrich-Miescher Institute for Biomedical Research, Basel, Switzerland
Suidan, Hana S
Monard, Denis
External co-authors :
yes
Language :
English
Title :
Prothrombin overexpressed in post-natal neurones requires blood factors for activation in the mouse brain.
Altrogge L. M. and Monard D. (2000) An assay for high-sensitivity detection of thrombin activity and determination of proteases activating or inactivating protease-activated receptors. Anal. Biochem. 277, 33-45.
Barnhart M. I. (1960) Cellular site for prothrombin synthesis. Am. J. Physiol. 199, 360-366.
Bar-Schavit R., Benezra M., Sabbah V., Vlodavsky I., Dejana E. and Wilner G. D. (1993) Functional domains in thrombin outside the catalytic site: cellular interactions. In: Thrombin: Structure and Function (Berliner L., ed.), pp. 315-350. Plenum Press, New York.
Beecher K. L., Andersen T. T., Fenton J. W. and Festoff B. W. (1994) Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J. Neurosci. Res. 37, 108-115.
Beilin O., Gurwitz D., Korczyn A. D. and Chapman J. (2001) Quantitative measurements of mouse brain thrombin-like and thrombin inhibition activities. Neuroreport 12, 2347-2351.
Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
Connolly A. J., Ishihara H., Kahn M. L., Farese R. V. Jr and Coughlin S. R. (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381, 516-519.
Coughlin S. R. (2000) Thrombin signalling and protease-activated receptors. Nature 407, 258-264.
Debeir T., Benavides J. and Vige X. (1996) Dual effects of thrombin and a 14-amino acid peptide agonist of the thrombin receptor on septal cholinergic neurons. Brain Res. 708, 159-166.
Debeir T., Benavides J. and Vige X. (1998) Involvement of protease-activated receptor-1 in the in vitro development of mesencephalic dopaminergic neurons. Neuroscience 82, 739-752.
Degen S. J., Schaefer L. A., Jamison C. S., Grant S. G., Fitzgibbon J. J., Pai J. A., Chapman V. M. and Elliott R. W. (1990) Characterization of the cDNA coding for mouse prothrombin and localization of the gene on mouse chromosome 2. DNA Cell Biol. 9, 487-498.
Déry O., Corvera C. U., Steinhoff M. and Bunnett N. W. (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am. J. Physiol. 274, C1429-C1452.
Deschepper C. F., Bigornia V., Berens M. E. and Lapointe M. C. (1991) Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res. Mol Brain Res. 11, 355-358.
Dihanich M., Kaser M., Reinhard E., Cunningham D. and Monard D. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581.
Gingrich M. B. and Traynelis S. F. (2000) Serine proteases and brain damage - is there a link? Trends Neurosci. 23, 399-407.
Gingrich M. B., Junge C. E., Lyuboslavsky P. and Traynelis S. F. (2000) Potentiation of NMDA receptor function by the serine protease thrombin. J. Neurosci. 20, 4582-4595.
Grand R. J., Grabham P. W., Gallimore M. J. and Gallimore P. H. (1989) Modulation of morphological differentiation of human neuroepithelial cells by serine proteases: independence from blood coagulation. EMBO J. 8, 2209-2215.
Ishihara H., Connolly A. J., Zeng D., Kahn M. L., Zheng Y. W., Timmons C., Tram T. and Coughlin S. R. (1997) Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386, 502-506.
Jalink K. and Moolenaar W. H. (1992) Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J. Cell Biol. 118, 411-419.
Jamison C. S. and Degen S. J. (1991) Prenatal and postnatal expression of mRNA coding for rat prothrombin. Biochim. Biophys. Acta 1088, 208-216.
Jia M., Li M., Dunlap V. and Nelson P. G. (1999) The thrombin receptor mediates functional activity-dependent neuromuscular synapse reduction via protein kinase C activation in vitro. J. Neurobiol. 38, 369-381.
Jiang Y., Wu J., Hua Y., Keep R. F., Xiang J., Hoff J. T. and Xi G. (2002) Thrombin-receptor activation and thrombin-induced brain tolerance. J. Cereb Blood Flow Metab 22, 404-410.
Kahn M. L., Zheng Y. W., Huang W., Bigornia V., Zeng D., Moff S., Farese R. V. Jr, Tam C. and Coughlin S. R. (1998) A dual thrombin receptor system for platelet activation. Nature 394, 690-694.
Kato H., Liu Y., Araki T. and Kogure K. (1991) Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res. 553, 238-242.
Kitagawa K., Matsumoto M., Kuwabara K., Tagaya M., Ohtsuki T., Hata R., Ueda H., Handa N., Kimura K. and Kamada T. (1991) 'Ischemic tolerance' phenomenon detected in various brain regions. Brain Res. 561, 203-211.
Lüthi A., Putten H., Botteri F. M., Mansuy I. M., Meins M., Frey U., Sansig G., Portet C., Schmut Z M., Schroder M., Nitsch C., Laurent J. P. and Monard D. (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J. Neurosci. 17, 4688-4699.
MacFarlane S. R., Seatter M. J., Kanke T., Hunter G. D. and Plevin R. (2001) Proteinase-activated receptors. Pharmacol. Rev. 53, 245-282.
McKinney M., Snider R. M. and Richelson E. (1983) Thrombin binding to human brain and spinal cord. Mayo Clin. Proc. 58, 829-831.
Mansuy I. M., van der Putten H., Schmid P., Meins M., Botteri F. M. and Monard D. (1993) Variable and multiple expression of protease nexin-1 during mouse organogenesis and nervous system development. Development 119, 1119-1134.
Minn A., Schubert M., Neiss W. F. and Muller-Hill B. (1998) Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV. Glia 22, 338-347.
Motohashi O., Suzuki M., Shida N., Umezawa K., Sugai K. and Yoshimoto T. (1997) Hirudin suppresses the invasion of inflammatory cells and the appearance of vimentin-positive astrocytes in the rat cerebral ablation model. J. Neurotrauma 14, 747-754.
Nick H., Hofsteenge J., Shaw E., Rovelli G. and Monard D. (1990) Functional sites of gial-derived nexin (GDN): importance of the site reacting with the protease. Biochemistry 29, 2417-2421.
Niclou S., Suidan H. S., Brown-Luedi M. and Monard D. (1994) Expression of the thrombin receptor mRNA in rat brain. Cell. Mol. Biol. 40, 421-428.
Niclou S. P., Suidan H. S., Pavlik A., Vejsada R. and Monard D. (1998) Changes in the expression of protease-activated receptor 1 and protease nexin-1 mRNA during rat nervous system development and after nerve lesion. Eur. J. Neurosci. 10, 1590-1607.
Nishino A., Suzuki M., Ohtani H., Motohashi O., Umezawa K., Nagura H. and Yoshimoto T. (1993) Thrombin may contribute to the pathophysiology of central nervous system injury. J. Neurotrauma 10, 167-179.
Nystedt S., Larsson A. K., Aberg H. and Sundelin J. (1995) The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression. J. Biol. Chem. 270, 5950-5955.
Rasmussen U. B., Vouret-Craviari V., Jallat S., Schlesinger Y., Pages G., Pavirani A., Lecocq J. P., Pouyssegur J. and Obberghen-Schilling E. (1991) cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization. FEBS Lett. 288, 123-128.
Riek-Burchardt M., Striggow F., Henrich-Noack P., Reiser G. and Reymann K. G. (2002) Increase of prothrombin-mRNA after global cerebral ischemia in rats, with constant expression of protease nexin-1 and protease-activated receptors. Neurosci. Lett. 329, 181-184.
Sekiya F., Usui H., Inoue K., Fukudome K. and Morita T. (1994) Activation of prothrombin by a novel membrane-associated protease. An alternative pathway for thrombin generation independent of the coagulation cascade. J. Biol. Chem. 269, 32441-32445.
Shikamoto Y. and Morita T (1999) Expression of factor X in both the rat brain and cells of the central nervous system. FEBS Lett. 463, 387-389.
Shikamoto Y., Shibusawa S., Okuyama I. and Morita T. (1997) Characterization of membrane-associated prothrombin activator in normal and injured murine tissues. FEBS Lett. 412, 526-530.
Small D. L., Monette R., Mealing G., Buchan A. M. and Morley P. (1995) Neuroprotective effects of w-Aga-IVA against in vitro ischaemia in the rat hippocampal slice. Neuroreport 6, 1617-1620.
Smith-Swintosky V. L., Cheo-Isaacs C. T., D'Andrea M. R., Santulli R. J., Darrow A. L. and Andrade-Gordon P. (1997) Protease-activated receptor-2 (PAR-2) is present in the rat hippocampus and is associated with neurodegeneration. J. Neurochem. 69, 1890-1896.
Soifer S. J., Peters K. G., O'Keefe J. and Coughlin S. R. (1994) Disparate temporal expression of the prothrombin and thrombin receptor genes during mouse development. Am. J. Pathol. 144, 60-69.
Stewart P. A. and Hayakawa E. M. (1987) Interendothelial junctional changes underlie the developmental 'tightening' of the blood-brain barrier. Brain Res. 429, 271-281.
Striggow F., Riek M., Breder J., Henrich-Noack P., Reymann K. G. and Reiser G. (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl Acad. Sci. USA 97, 2264-2269.
Striggow F., Riek-Burchardt M., Kiesel A., Schmidt W., Henrich-Noack P., Breder J., Krug M., Reymann K. G. and Reiser G. (2001) Four different types of protease-activated receptors are widely expressed in the brain and are upregulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14, 595-608.
Suidan H. S., Stone S. R., Hemmings B. A. and Monard D. (1992) Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8, 363-375.
Turgeon V. L., Milligan C. E. and Houenou L. J. (1999) Activation of the protease-activated thrombin receptor (PAR)-1 induces motoneuron degeneration in the developing avian embryo. J. Neuropathol. Exp. Neurol. 58, 499-504.
Vaughan P. J., Pike C. J., Cotman C. W. and Cunningham D. D. (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389-5401.
Vu T.-K. H., Hung D. T., Wheaton V. I. and Coughlin S. R. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
Weinstein J. R., Gold S. J., Cunningham D. D. and Gall C. M. (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J. Neurosci. 15, 2906-2919.
Xi G., Keep R. F., Hua Y., Xiang J. and Hoff J. T. (1999) Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30, 1247-1255.
Xu W. F., Andersen H., Whitmore T. E., Presnell S. R., Yee D. P., Ching A., Gilbert T., Davie E. W. and Foster D. C. (1998) Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA 95, 6642-6646.